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Full PaperEncapsulation and Survival of a Chondrocyte
Cell Line within Xanthan Gum DerivativeaAna C. Mendes,* Erkan T. Baran, Rui C. Pereira, Helena S. Azevedo, Rui L. ReisA chemical derivative of xanthan gum polysaccharide is investigated as a new artificial
matrix for the encapsulation of chondrocytic cells. Toward this goal, a novel micro-droplet
generator is developed to produce microcapsules. Microcapsules with an average diameter
of 500mm, smooth surface, and homo-
geneous size distribution are obtained.
ATDC5 cells encapsulated in carboxy-
methyl xanthan (CMX) microcapsules
remain viable and are observed to pro-
liferate for prolonged culture periods
with enhanced metabolic activity.
Furthermore, retention of the chondro-
genic phenotype is exhibited by the
cells within CMX, suggesting the
ability of this material to be applied
in cell-delivery therapies.1. Introduction
Cell microencapsulation is a technology with enormous
clinical potential for the treatment of a wide range of
human diseases such as diabetes,[1–3] hemophilia, anemia,
hypoparathyroidism, renal failure,[1,4–7] osteoarthritis,[8–14]
and also for constructing artificial organs.[1] In cell
encapsulation, cells are protected from immune rejectionA. C. Mendes, E. T. Baran, R. C. Pereira, H. S. Azevedo, R. L. Reis
3B’s Research Group – Biomaterials, Biodegradables and
Biomimetics, University of Minho, Headquarters of the European
Institute of Excellence on Tissue Engineering and Regenerative
Medicine, AvePark, 4806-909 Taipas, Guimara˜es, Portugal, and
ICVS/3B’s PT Government Associate Laboratory, Braga/
Guimara˜es, Portugal
E-mail: ana.mendes@dep.uminho.pt
a Supporting Information for this article is available from the Wiley
Online Library or from the author.
Macromol. Biosci. 2011, 11, 000–000
 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim wileyonlin
Early View Publication; these are NOTby an artificial, semipermeable membrane, potentially
allowing transplantation (allo- or xenotransplantation)
without the need for immunosuppression.[1,4–7,15–18] For
the clinical success of cell encapsulation, it is crucial to have
a source of cells, a biocompatible, as well as mechanically
and chemically stable membrane of suitable permeability,
which is able to provide immune protection to the
implant.[1,4–6,15,16] Although efforts have been made in
order to accomplish these goals, the available systems still
present limitations regarding their reproducibility during
microcapsule preparation and long-term viability of
encapsulated cells. During the past decade, several poly-
electrolytes, such as polysaccharides and polypeptides,
have been widely used for the fabrication of capsules, due
their ability to form gels through complexation with
oppositely charged polymers (e.g., alginate/poly-L-lysine
(PLL)[3,17]) or by ionic crosslinking of the polyanionic
biopolymer in the presence of a counterion (e.g., Ca2þ,
Ba2þ). In these cases, the gelation processes is cell-elibrary.com DOI: 10.1002/mabi.201100304 1
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Figure 1. Chemical structure of (a) xanthan repeating unit and (b) CMX.
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harsher chemicals, and the gels provide a
highly hydrated three-dimensional (3D)
network. Furthermore, these materials
can be injected into the body, hence
enabling the clinician to transplant the
cell-polymer combination in a minimally
invasive way.[19]
Cell based therapies have demon-
strated an enormous potential for the
long term repair of cartilage defects[8–14]
and the alginate-based hydrogels have
been widely used as a convenient 3D cell
culture model system.[9–11,13,20,21] This
system has demonstrated the ability to
prevent chondrocytes from undergoing
de-differentiation as well as restore
cartilaginous phenotype to de-differen-
tiated chondrocytes.[22] In addition, algi-
nate systems have shown to promote the
synthesis of cartilage matrix compo-
nents, such as proteoglycans and col-
lagen type II.[21,23]
Although alginate/PLL polyelectrolyte
complexes have been widely investi-
gated for cell encapsulation, they still
present some drawbacks concerning
their long-term mechanical performance
and biocompability.[7,24]
Xanthan gum is an extracellular poly-
saccharide produced by the bacterium
Xanthomonas campestris.[25–28] The pri-
mary structure of xanthan consists of
b(1! 4)-linked glucose units, similar to
the structure of cellulose backbone, sub-
stituted at O-3 of alternate glucose
residues, with a trisaccharide. The trisac-
charide consists of one glucuronic acidunit between two mannose units (Figure 1a). The terminal
mannose moiety may carry pyruvate residues linked to
the positions 4 and 6 with an unknown distribution.
D-Mannose unit linked to the main chain contains an acetyl
group at position O-6.[25–29] The pyruvic acid content of
xanthan can vary substantially depending on the strain of
X. campestris, resulting in different viscosities of xanthan
solutions. Molecular modeling studies suggest that
xanthan gum can assume a helical structure, with the side
branches positioned almost parallel to the helix axis and
stabilizing the structure.[25–27,29] The presence of acetic and
pyruvic acids is the main responsible for the polyanionic
character of this polysaccharide. Xanthan forms very
viscous solutions, and, at sufficiently high polymer con-
centration, it exhibits weak gel-like properties.[25,30]
Furthermore, it was shown to be biocompatible,[28]Macromol. Biosci. 20
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and pharmaceuticals because of its encouraging reports on
safety.[25]
The application of other microbial polysaccharides with
gelling properties, such as gellan gum, has been reported in
the literature for the encapsulation of human chondrocytes
for cartilage regeneration[31] but to the best of our
knowledge, the use of xanthan gum as cell encapsulation
matrix has only been described by our group.[32] Therefore,
the present work aims to investigate the potential of a
xanthan derivative [carboxymethyl xanthan (CMX)] as a
new matrix for the encapsulation of ATDC5 cell line which
has been widely used as a model to study chondrogenic
differentiation in vitro.[33–37] To test our hypothesis, we
have used a simple microdroplet generator, based on a
tubing system, to produce microcapsules with homoge-11, 11, 000–000
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mass transfer and easy injects for cell therapy. In vitro
studies were performed to evaluate the ability of the CMX
microcapsules to support cell viability, proliferation, and
cell functions.2. Experimental Section
2.1. Materials
All chemicals, including xanthan gum from X. campestris,
monochloroacetic acid, and poly-L-lysine, were obtained from
Sigma-Aldrich unless otherwise indicated. The chemicals were
used as received.2.2. Determination of Molecular Weight of Native
Xanthan
The average molecular weight (Mw) was determined by size-
exclusion chromatography (SEC). The samples were dissolved in an
aqueous 0.1 M NaNO3 solution (0.4% w/v). A PL-GPC 110 chromato-
graph was equipped with a pre-column PLaquagel-OH 15mm and
two SEC columns in series (PLaquagel-OH40 15mm, 3007.0 mm2
and PLaquagel-OH60 15mm, 3007.0 mm2). The pre-column, the
SEC columns, the injection system, and the refractive index detector
were maintained at 36 8C. The eluent (aqueous 0.1 M NaNO3
solution) was pumped at a flow rate of 0.9 mL min1. The
analytical columns were calibrated with pullulan standards
(Polymer Laboratories, UK) in the range of 5.8–1600 kDa. The
average molecular weight of xanthan gum was estimated as
152 kDa.[32]2.3. CMX Synthesis
CMX was prepared by adapting the carboxmethylation procedure
used for chitosan by Chen and Park.[38] 10 g of xanthan from
X. campestris and 13.5 g sodium hydroxide (Panreac, Spain) were
mixed in 100 mL of solvent mixture of water/isopropyl alcohol
(Fluka, Germany) using a top stirrer. The mixture was allowed to
react at 50 8C in a water bath (Thermostat IKA, Germany) for 1 h.
Two solvent mixtures were used (1:1 and 1:4 v/v) to yield xanthan
with different degrees of carboxymethylation designated by
CMX1 and CMX2, respectively. Then, 15 g monochloroacetic acid,
dissolved in 20 mL of isopropyl alcohol, were added dropwise to the
reaction mixture for 30 min. The reaction was carried out for 4 h at
the same temperature and stopped by adding 200 mL of ethanol
70% (Panreac, Spain). At the end, the obtained solid precipitate was
filtered and rinsed with 70–90% of ethanol to desalt and dewater
and further vacuum dried at room temperature.2.4. CMX Characterization
2.4.1. FTIR Spectroscopy
The chemical modification of xanthan was analyzed by infrared
spectroscopy in an IR Prestige-21 (SHIMADZU, Japan) spectro-www.MaterialsViews.com
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Techonologies, USA) pellets were prepared by mixing the CMX
powder with KBr (CMX/KBr, 1:10 w/w). The spectrum was taken
with the average of 32 scans and a resolution of 4 cm1.
2.4.2. Determination of the Degree of Substitution (DS)
The DS of CMX was determined by acid/base titration. CMX (0.2 g)
was dissolved in 40 mL of distilled water. The pH of the solution was
adjusted to 2 with hydrochloric acid and then CMX was titrated
with 0.1 N NaOH. The volume of added NaOH, as well as the pH
values, were recorded. Three replicates were performed for each
sample. DS was calculated following the calculation procedure
used for carboxymethyl chitosan and described by Ge and Luo[39] as
follows:1, 000–
H & Co
theDS ¼ MXru  nep
 
0:2 MCM  nep
  (1)where MXru is the molecular weight of Xanthan repeating unity
(851), nep the number of mol of carboxymethyl groups at the
ending point of the titration, and MCM is the molecular weight of
the carboxymethyl groups inserted in the native structure of
Xanthan gum.2.5. Cell Culture and Encapsulation
The murine ATDC5 chondrocyte cells were cultured in basic
medium, consisted of Dulbecoo’s modified Eagle medium (DMEM,
Sigma-Aldrich, USA) with phenol red, supplemented with 10% fetal
calf serum (FCS, Biochrom AG, Germany), 5103 M L-glutamine
(Sigma, USA) and 1% of antibiotic/antimycotic mixture (Sigma,
USA) and maintained at 37 8C in a humidified atmosphere of 5%
CO2. The medium was replaced every 2 d. At passage 7, cells were
detached with trypsin/ethylenediamine tetraacetate (EDTA) and
counted in a hemacitometer for encapsulation.
The cells were encapsulated into CMX microcapsules using a
novel in house micro-droplet generator[40] as illustrated in
Figure 2A. In this system, an autoclavable tubing (Novosil, Fisher
Scientific, USA) with 1 mm internal diameter was punctured with a
blunt end needle in a vertical position and sealed with a silicone
glue. This assembly can be autoclaved numerously and can be
assembled with peristaltic pump (Ismatec, Switzerland) and
syringe pump (Alladdin WPI, England) as shown in Figure 2B.
One end of the tubing was connected to an oil reservoir (Aldrich,
Germany) and the other end to a glass collector where the droplets
were cured in a crosslinker solution. A magnetic top stirring
apparatus, made up of Teflon with a magnet, was placed on the top
of collector in order to stir solution without introducing a
mechanical stress on the formed microcapsules. The operation
rate of peristaltic and syringe pump was set at 0.35 mL min1 and
20mL min1, respectively.
Prior to encapsulation, CMX powder (sterilized by autoclaving
for 10 min at 121 8C) was dissolved in DMEM (5 wt%) until
obtaining a homogeneous solution. Subsequently, a cell suspension
at cellular density of 107 cells mL1 was mixed with aqueous CMX
solution. The microdroplets generated by the device were fed into
the crosslinker solution containing 1.5% CaCl2 (Merck Chemical Co.,000
. KGaA, Weinheim 3
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Figure 2. (A) Schematic representation of the micro-droplet generator. (B) Photograph showing the apparatus used to produce the
microcapsules.
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The CMX capsules were stirred gently for 15 min and then washed
with phosphate-buffered saline (PBS, Sigma, USA) in order to
remove traces of mineral oil. Afterwards, the collected micro-
capsules were transferred into a PLL solution (0.1 wt%, 30–70 kDa)
for 10 min in order to strengthen the outer surface of the
microcapsules. Finally, the coated microcapsules were transferred
to DMEM culture medium and cultured in a 24-well polystyrene
plate, previously coated with agarose (4 wt% in PBS) to avoid the
adhesion of non-encapsulated cells.
Alginate (alginic acid sodium salt from brown algae,
Mw ¼ 100 kDa, Fluka, Norway) was used to produce microcapsules
to serve as controls. They were also produced following a procedure
similar to the one described for CMX microcapsules. The alginate
microcapsules were successively coated with the PLL (0.05 wt%) for
5 min (see Supporting Information).
The encapsulated cells (n¼ 3) were maintained in vitro culture
for a period of 3 weeks in DMEM with media exchange every 2 d.
Empty microcapsules were also maintained throughout the culture
period to serve as controls.
2.5.1. Microcapsule Characterization
Light Microscopy
Microscopic observations of the encapsulated cells and controls
were carried out over the course of the in vitro culture to examine
the cell morphology and growth. A bright field light microscope
(AXIOVERT 40 CFL, Zeiss, Germany) equipped with a digital camera
(Canon Power shot G8, Japan) was used and images were acquired
at 10 magnification.
Scanning Electron Microscopy (SEM)
Prior to the SEM observations, the microcapsules were fixed with
glutaraldehyde (Electron Microscopy Sciences, USA) solution
(3 vol% in PBS) at 4 8C for 1 h. The samples were further dehydrated
in a graded ethanol series (20, 50, 60, 70, 80, 90, and 100%) followedMacromol. Biosci. 20
 2011 WILEY-VCH Verlag Gmb
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Microscopy Sciences, USA). Microcapsules were cut in half to expose
the membrane cross-section and the internal surface of micro-
capsules. The specimens were mounted on aluminum stubs and
sputter coated with Pt/Pd target (80:20) generating a thin film with
6 nm of thickness (208 HR High Resolution Sputter Coater,
Cressington). The microcapsules were imaged on an ultra-high
resolution field-emission gun scanning electron microscope (FEG-
SEM, FEI Nova 200 NanoSEM).
Cell Viability and Proliferation Post-Ecapsulation
To investigate if the CMX microcapsules can support cell viability
and proliferation, encapsulated cells were examined using several
biochemical analyses. Viability of cells was assessed by fluores-
cence microscopy using a live/dead assay; the metabolic activity of
the encapsulated cells was analyzed by the AlamarBlue assay and
cell proliferation evaluated by DNA quantification.
Live/Dead Cell Assay
Calcein AM (Sigma, USA) solution (2:1000 v/v) was prepared in
DMEM medium without FCS and phenol red. Propidium iodide (PI,
Molecular Probes, Invitrogen, USA) solution was prepared by
mixing 2mL PI (1 mg mL1) with 20mL (1 mg mL1) RNAse A (USB
corporation, USA) and 2 mL PBS. The microcapsules with encapsu-
lated cells and controls were collected from the culturing plates and
incubated with calcein-AM and PI solutions at 37 8C for 10 min
protected from light. Samples were then observed under fluor-
escent microscopy using an Axioplan Imager Z1m microscope
(Zeiss, Germany).
Metabolic Activity of Encapsulated Cells – AlamarBlue1
Assay
The metabolic activity of encapsulated cells over time was assessed
using the AlamarBlue assay (AbD Serotec, UK). AlamarBlue was
added (10% of the volume of the well) to each well containing the
encapsulated cells and the plate was incubated at 37 8C for 20 h11, 11, 000–000
H & Co. KGaA, Weinheim www.MaterialsViews.com
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Figure 3. (A) FTIR spectra of native xanthan and carboxymethy-
lated xanthans with different degrees of modification (CMX1 and
CMX2). (B) DS obtained from acid/base titration.
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from each well and placed in a 96 well plate. The absorbance
was read at 570 and 600 nm on a microplate reader (BioTek, Synergy
HT, USA). The percentage of reduced AlamarBlue was calculated
according the manufacturer instructions.
Cellular Proliferation Assay
ATDC5 proliferation within the capsules was determined using a
fluorimetric dsDNA quantification kit (PicoGreen, Molecular Probes,
Invitrogen, USA). For this purpose, the samples collected at days 1, 7,
14, and 21 were washed twice with sterile PBS (Sigma, USA) solution
and transferred into 1.5 mL microtubes containing 1 mL of ultra-pure
water. Capsules with and without cells were stored at 80 8C until
further analysis. Prior to DNA quantification, samples were thawed
and broken by pipetting up and down using a syringe with a needle
to cause material disruption and facilitate DNA extraction. 28.7mL of
each sample and standards (0–2 mg mL1) were transferred to an
opaque 96 well plate. Then 71.3mL of PicoGreen solution and 100mL
of Tris/EDTA buffer were added. Standards and samples were
prepared in triplicate. The plate was incubated for 10 min in the dark
and the fluorescence was measured using an excitation wavelength
of 485 nm and emission of 528 nm. DNA amounts were calculated
from the calibration curve.
Histology
Cell cultured microcapsules for histology were rinsed three times in
PBS and then fixed in 3.7% formalin in PBS for 1 h at room
temperature. After fixation, samples were dehydrated in a graded
ethanol series (70, 90, 95, and 100%) followed by immersion in
xylene. Specimens were embedded in paraffin and cut in 4mm-
thick sections (Microm HM355S Microtome, Inopat, USA). Sections
were then dewaxed and stained with Harris Hematoxylin (Sigma,
USA) and eosin (H&E staining).2.6. Statistical Analysis
Results of DNA quantification and cell viability are expressed as
a mean standard deviation with n¼3 for each group. Statistical
significance of differences was determined using unpaired
student’s t-test multiple comparison procedure at a confidence
level of 95% (p<0.05).3. Results and Discussion
3.1. CMX Characterization
When designing materials for cell encapsulation, several
properties should be considered. For instance, the amount
and the character of functional groups contained in
monomer units will influence the intermolecular interac-
tions and consequently complex formation. Complexation
is enhanced by the charge density in the polyanion, which
depends on the chemical structure, the pKa of the
polyelectrolyte, as well the pH of the solution. Xanthan
by itself is able to form self-supporting gels in the presence
of ions, although they are not stable in presence of aqueouswww.MaterialsViews.com
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xanthan was carboxymethylated and its chemical compo-
sition was characterized in order to control capsule
properties and performance in biological solutions. The
chemical modification on xanthan was confirmed by FTIR
spectra (Figure 3A) by the decrease of the COH band
intensity at 1425 cm1 and OH stretching at 3400 cm1. In
addition, the absorption band at 1616 cm1, attributed to
C¼O groups of pyruvate, was increased significantly after
carboxymethylation, while the carbonyl peak, which is
provided by the acetate at 1741 cm1 in native xanthan,
was not observed in CMX. This may indicate that the acetyl
group was hydrolyzed by sodium hydroxide during
carboxymethylation and consequently converted into
carboxymethyl group.
Comparing the spectra of modified xanthans, CMX2
presents more evident changes than CMX1 when compared
with native xanthan, indicating higher level of modifica-
tion. To confirm this hypothesis, we determined the DS
which was found to be higher for CMX2 (4.38) than for
CMX1 (0.35) (Figure 3B). Due to the higher DS of CMX2 and
its ability to form gels, we selected this carboxymethylated
xanthan for subsequent encapsulation studies.3.2. Microcapsule Preparation and Encapsulation
of Cells
A simple microencapsulation process was developed by
using a silicone tubing and blunt ended syringe needle1, 000–000
H & Co. KGaA, Weinheim 5
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Figure 4. SEM images showing the overall structure of CMX microcapsules (A), the microstructure of the microcapsule external surface
(B, C) and cross-section of microcapsule membrane (D). (E) Zoom/in of (D) showing the interface between CMX and PLL complex.
(F, G) Magnified images revealing morphological details of CMX and PLL layers, respectively.
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for advance techniques and skills which are required for
preparation of microfluidic devices. The size of microcap-
sules can be adjusted by using tubing at desired internal
diameter that are commercially available in wide size
range. The device can be sterilized by autoclaving and
connected to pumps easily on aseptic conditions. The first
step of microcapsule formation is the extrusion of the
polymer solution through the micro-droplet generator
which enables a homogeneous size distribution. The
microcapsules were then formed by crosslinking of
generated droplets in a crosslinking solution while preser-
ving physiological conditions for cells.
The morphology and microstructure of the microcap-
sules were analyzed using SEM (Figure 4). Capsules with
spherical shape and a diameter of 500mm were obtained. At
higher magnifications (Figure 4B, C) the microcapsule
external surface appears to be quite smooth. Their relatively
small and uniform size (high surface to volume ratio) has
been considered advantageous under a mass transport and
immunological response perspectives.[4,15,16,41] At the
same time, capsules with rough surfaces should be avoided
since they can elicit immunological reactions when
implanted.[15,41]
SEM images of the microcapsule cross-sections
(Figure 4D) reveal an amorphous membrane with thickness
of about 5mm and two layers with distinct morphologies.Macromol. Biosci. 20
 2011 WILEY-VCH Verlag Gmb
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results in a porous matrix. The Image J software (NIH, USA)
analysis showed that those structures have highly con-
served dimension with the mean width of 35.97 6.3
(Figure 4C) and 29.89 6.9 nm (Figure 4G) from capsule
surface and cross-sectioned area of microcapsule wall,
respectively. This result may indicate that the complex
formation between PLL and CMX might be affected by
macromolecular tertiary structure of both biopolymers and
as a result, reproducible tubular structures were formed. A
successful capsule membrane for cell transplantation
should allow rapid diffusion of nutrients, wastes, and
important metabolic products. From those fibrous network
structures it can be expected that the capsule wall can be
quite permeable to nutrients and permit high viability
conditions for encapsulated cells inside microcapsule.
Moreover, it is expected that the permeability of the
capsules can be controlled by changing the degree of
modification of xanthan, the concentration and molecular
weight of both polymers (xanthan and PLL).
Cytotoxicity is an important criterion for any biomater-
ials used in tissue engineering. We analyzed the cyto-
toxicity of the CMX capsules over ATDC5 cells via MTS [3-
(4,5-dimethylthiazol-2-yl)-2-(4-sulfophenyl)-2H-tetrazolium
salt] assay (data not shown). Cells were exposed to the
extracts from CMX capsules in contact with culture
medium for 24, 48, and 72 h. Latex rubber extract and fresh11, 11, 000–000
H & Co. KGaA, Weinheim www.MaterialsViews.com
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Figure 5. In vitro viability and proliferation of ATDC5 cells cultured in CMX microcapsules. (A) Fluorescence microscopy images displaying the
live/dead assay of encapsulated cells (green cells are live, red cells are dead) showing that the cells remain viable in the microcapsules up to
21 d of culture. (B) Metabolic activity and (C) proliferation of encapsulated cells determined by AlamarBlue assay and DNA quantification.
Results are expressed as means standard deviation with n¼ 3. indicates significant difference (p<0.05) between different time points
for CMX microcapsules.
Encapsulation and Survival of a Chondrocyte . . .
www.mbs-journal.decomplete culture medium were used, respectively, as
negative and positive controls. The results showed
that the CMX capsules do not cause any deleterious
change in the metabolic activity of ATDC5 cells and
consequently CMX capsules can be considered safe for cell
encapsulation.3.3. In vitro Viability and Proliferation of ATDC5 Cells
Cultured within Microcapsules
In vitro studies are necessary to ensure that CMX
microcapsules did not cause cell death or inhibit cell
proliferation.
The morphology (Figure 6A) and viability (Figure 5A and
B) of encapsulated cells were investigated after several days
in culture. Cells formed small aggregates with strong green
fluorescence observed inside the capsule (Figure 5A),
demonstrating high viability of ATDC5 cells post-encapsu-
lation. Furthermore, an even cell distribution can be
observed throughout the culturing time (Figure 5A and
6A) in CMX microcapsules, but in the latest times (14 and
21 d), ATDC5 cells encapsulated in CMX showed their
tendency to form cellular aggregates (Figure 5A) demon-www.MaterialsViews.com
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SEM also revealed the formation of cell aggregation inside
the capsules (Figure 7D and E).
The metabolic activity of ATDC5 cells was investigated
throughout the culturing period using AlamarBlue assay
(Figure 5B). The results showed that ATDC5 cells encapsu-
lated in CMX matrix were able to reduce AlamarBlue over
the 21 d of in vitro culture (Figure 5B).
To support the results provided from AlamarBlue assay,
cell proliferation was investigated by DNA quantification.
DNA quantification (Figure 5C) revealed a steady and
significant (p< 0.05) increase in the DNA amounts with
culturing time as a result of improved cellular proliferation
in CMX microcapsules. A common limitation of poly-
electrolyte complexes is lack of permeability to larger
molecules, such as proteins, because these systems are
normally characterized by a dense membrane structure.[42]
The ATDC5 cells remained viable within microcapsules for
up to 3 weeks in culture. The CMX microcapsules could
therefore provide sufficient nutrient diffusion necessary for
cell survival and proliferation.
ATDC5 is a very well established cell line known to be an
excellent in vitro chondrogenic model for determining1, 000–000
H & Co. KGaA, Weinheim 7
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Figure 6. Bright field light microscopy images of (A) living cells encapsulated in CMX microcapsules and (B) microcapsule sections stained
with H&E after different culturing times.
Figure 7. SEM images showing the interior of the CMX microcapsules after 1 and 21 d of culture. (A, B) Morphological characteristics of the
cells attached to the microcapsule inner surface. (D, E) Cell aggregates formed after 21 d of culture. (C, F) Microstructure of the microcapsule
inner surface showing highly porous structure (F).
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tions during chondrogenesis are promoted by the 3D
environment.[34] In CMX microcapsules, ATDC5 cells
retained their tendency to form cellular aggregates and
they expressed high metabolic activity.
H&E staining of cells encapsulated in the CMX micro-
capsules (Figure 6B) revealed that ATDC5 cells retained their
rounded morphology throughout the culture time and tendMacromol. Biosci. 20
 2011 WILEY-VCH Verlag Gmb
rly View Publication; these are NOT the final pagto form cartilage nodule-like aggregates after 21 d of culture
in the CMX microcapsules. This fact denotes that CMX
microcapsules promoted the retention of the chondrocytic
phenotype.
SEM analysis on cell cultured microcapsules revealed
that the cells attached on the internal microcapsule surface,
interact with the surrounding matrix by their extended
filopodias (Figure 7B and E) and tend to form small11, 11, 000–000
H & Co. KGaA, Weinheim www.MaterialsViews.com
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the presence of ATDC5 cells and aggregates on the capsule
wall may be a result of higher nutrient availability in these
regions, since it is expected a better diffusion of nutrients
near the capsule wall surface. At higher magnification, SEM
image (Figure 7F) shows a fibrillar microstructure typical of
natural ECM. Such fibrillar structure may offer additional
advantages, when compared to the dense structure of other
systems used for producing capsules, as it might allow a
better control over capsule permeability.
In the current work, we have used a standard cell line to
evaluate the ability of CMX microcapsules to support cell
viability and proliferation. Given these encouraging pre-
liminary results, we envision the encapsulation of human
articular chondrocytes in CMX to be applied as cell-based
therapies in cartilage tissue engineering approaches.4. Conclusion
This study presents a novel process that utilizes a micro-
droplet generator to prepare microcapsules using the
xanthan gum polysaccharide. The optimized process
conditions enabled generating microcapsules with long-
term stability and the encapsulation of a chondrocytic cell
line. Encapsulated cells showed high viability (the cells
survive in culture for at least 3 weeks) and retained the
property of forming cell aggregates. In conclusion, our
studies suggest that CMX can be an alternative to the
current cell encapsulating materials, but in vivo studies are
necessary to confirm our hypothesis. Nonetheless, CMX
microcapsules may offer significant potential for long term
cell culture in bioreactors for applications in cell therapies.Acknowledgements: This work was supported through the
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